JAMA Internal Medicine recently published an article this April that sought to examine the link between sildenafil use and the risk of incident melanoma among men in the United States. Sildenafil is the active ingredient in Viagra, an oral medication approved by the FDA to treat erectile dysfunction and which has been around since 1998. In that time, the drug, which is manufactured by Pfizer, has been prescribed to over 22 million men.
In its report, JAMA Internal Medicine warned that men who took sildenafil demonstrated an increased risk for melanoma. Although their current results are not enough to change clinical recommendations, . from Brigham and Women’s Hospital cautions that "our data provides epidemiological evidence on possible skin adverse effects of PDE5A inhibitors (sildenafil citrate in Viagra) and support continued investigation of this relationship." Ongoing studies will attempt to better understand the correlation between increased occurrences of melanoma and the use of Viagra.
Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Viagra and its dangerous side effects and the following psychological trauma. If you or a loved one has experienced any of these side effects you should contact one of our attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Viagra lawyer, Majed Nachawati at , or by calling our office at 1.866.705.7584.
About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing AndrGel and other similar testosterone therapy victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.